SCHD Delivers a Rare 20% Return, Beating the Nasdaq-100 in 2026 📌

The Quiet Outperformance of a Dividend Giant 📈

In a year where high-flying AI stocks have stumbled, a conservative income fund has taken the lead. The Schwab U.S. Dividend Equity ETF (SCHD) has delivered a striking 20% return in 2026, comfortably ahead of the S&P 500's 11% and the Nasdaq-100's 17%.

This is not a typical market cycle. For most of the AI boom, growth indexes dominated. Yet here we are, watching a $95 billion portfolio of household names like Coca-Cola and Procter & Gamble hit a 52-week high while yielding a juicy 3.2%. The fund charges a mere 0.06% in expenses, making it a favorite for cost-conscious income investors.

Let's break down the mechanics behind this surprising rally and what it means for your portfolio.

SCHD Dividend ETF chart outperforming Nasdaq 100 in 2026 Economic Flow Reference

How SCHD's Screening Rules Create a Moat 🛡️

SCHD tracks the Dow Jones U.S. Dividend 100 Index, which employs a rigorous, rules-based selection process that actively avoids the hype.

The Admission Criteria:

A company must have 10 consecutive years of dividend payments.
REITs and MLPs are excluded.
From the eligible pool, the index ranks stocks on four fundamentals:
1. Free cash flow to total debt
2. Return on equity (ROE)
3. Dividend yield
4. Five-year dividend growth rate

The Resulting Portfolio:

No single stock exceeds 4% of the index.
No sector exceeds 25%.
The top holdings are UnitedHealth Group, Home Depot, and Abbott Laboratories.
Healthcare and Consumer Staples each make up ~21% of the fund.

This screening naturally filters out high-growth but low-yield names. You won't find Nvidia, Microsoft, or Alphabet in the top 25. In 2026, this exclusion has turned from a drag into a superpower.

The market is divided on whether SCHD's outperformance is sustainable. Here's what the bulls and bears are saying:

🐮

Bull (Optimist)

SCHD's quality screen is its secret weapon. By filtering for free cash flow and ROE, it avoids yield traps. The current rotation into value is just getting started. With a 3.2% yield and a P/E of 17x, this is a no-brainer for income investors. 🚀

Bear (Pessimist)

This is a classic 'rearview mirror' trade. The moment AI stocks catch a bid, SCHD will be left in the dust. You're buying at a 52-week high after a 20% run—that's chasing performance. The yield is nice, but total return will lag if growth reasserts itself. ⚠️

🐻

Bull market for dividend stocks and value investing Global Economy Image

Why the 'Boring' Portfolio is Winning in 2026 🔄

The outperformance isn't magic—it's sector rotation. After a multi-year rally, many high-multiple software and AI names are under pressure. Capital is rotating toward:

Defensive drugmakers (e.g., Merck, AbbVie)
Household staples (e.g., Coca-Cola, P&G)
Energy giants (e.g., Chevron)

SCHD was already heavily weighted in these three areas. The fund's portfolio also trades at a P/E of ~17x, compared to the mid-20s for the S&P 500. Investors are essentially buying a cheaper basket of durable businesses while getting paid 3.2% to wait.

Key Data Snapshot 📊

Metric	SCHD	S&P 500	Nasdaq-100
YTD Return (2026)	20%	11%	17%
Dividend Yield	3.18%	~1.3%	~0.6%
P/E Ratio	~17x	~24x	~30x
Expense Ratio	0.06%	N/A	N/A

Data as of mid-2026.

Over the past 12 months, the Nasdaq-100 still leads with a ~30% return vs. SCHD's 27%. But the trend has clearly shifted. This year's flip-flop suggests the growth trade had simply become too expensive.

📊 In-Depth Fundamental Analysis

Company	Share Price	P/E Ratio	P/B Ratio	ROE	Operating Margin (OPM)	Revenue Growth
ABT (Abbott)	$101	28.20	3.35	0.00%	14.15%	13.00%
CVX (Chevron)	$187	32.70	2.02	6.64%	7.31%	2.30%
GOOG (Alphabet)	$346	26.38	8.76	38.88%	36.12%	21.80%
GOOGL (Alphabet)	$347	26.45	8.78	38.88%	36.12%	21.80%
HD (Home)	$339	24.10	24.35	128.38%	11.93%	4.80%
KO (Coca-Cola)	$82	25.65	10.44	43.37%	35.05%	12.10%
MSFT (Microsoft)	$394	23.47	7.06	34.01%	46.33%	18.30%
NVDA (NVIDIA)	$203	31.06	25.13	114.29%	65.60%	85.20%
PG (Procter)	$150	21.93	6.50	31.11%	23.05%	7.40%
UNH (UnitedHealth)	$426	32.06	3.95	14.15%	7.13%	0.40%

Scenario Analysis: What Happens Next? 🎯

🟢 Best-Case Scenario (Bullish for SCHD)

Continued Rotation: If AI earnings disappoint further or interest rates stay elevated, capital continues flowing into value and income.
Steady Income Growth: SCHD's holdings raise dividends, pushing the effective yield higher even as the share price appreciates.
Outcome: SCHD ends 2026 with a 25%+ total return, cementing its reputation as a low-volatility winner.

🔴 Worst-Case Scenario (Bearish for SCHD)

AI Resurgence: Nvidia and other tech giants rally hard in H2 2026, sucking capital back into growth.
Dividend Cuts: A recession hits consumer staples and healthcare harder than expected, forcing dividend reductions.
Outcome: SCHD underperforms the Nasdaq-100 by 10%+ in the second half, ending the year with a flat or negative total return.

Conclusion: A Solid Anchor, Not a Sprint 🏠

SCHD's job isn't to beat the Nasdaq-100 every year. Its job is to deliver a growing income stream from durable businesses with less drama. It has compounded at ~13% annually since inception—a remarkable track record.

For long-term investors seeking income and stability, SCHD remains a solid buy even near its high. The rules that built it haven't changed. And after a year like this, calling them 'boring' feels like a compliment.

Risk Warning: Past performance is not indicative of future results. Dividend payments are not guaranteed and can be cut. This analysis is for informational purposes only and does not constitute financial advice.

📚 Recommended Reading

Passive income strategy with Schwab U.S. Dividend Equity ETF Financial Market Scene

This content was drafted using AI tools based on reliable sources, and has been reviewed by our editorial team before publication. It is not intended to replace professional advice.

SCHD Delivers a Rare 20% Return, Beating the Nasdaq-100 in 2026 📌

The Quiet Outperformance of a Dividend Giant 📈